Here are the five most-read stories about gastroenterology and endoscopy from Nov. 12-20:
GI & Endoscopy
FDA-approved colonoscopy prep pill, US Digestive partners with GI practice & more — 4 industry notes
Here are four updates from GI companies and practices from the past week:
Exton, Pa.-based US Digestive Health partnered with West Chester (Pa.) GI Associates, the platform announced Nov. 17.
Jacksonville, Fla.-based Digestive Disease Consultants is building a second ASC in the city, according to Abdi Abbassi, MD, a gastroenterologist with the practice.
While only 5.1 percent of COVID-19 patients admitted to intensive care units had severe gastrointestinal complications, those patients had a mortality rate of 55.6 percent, according to a pre-proof study published in Gastroenterology.
Gastroenterologist and colorectal cancer screening pioneer David Ahlquist, MD, died Nov. 1 of amyotrophic lateral sclerosis. He was 69.
Oceanside, N.Y.-based Mount Sinai South Nassau broke ground on a 15,400-square-foot facility in Long Beach, N.Y., the health system announced Nov. 10.
The FDA approved Sebela Pharmaceuticals' colonoscopy preparation tablet Sutab, the company announced Nov. 10.
Here are the five most-read stories about gastroenterology and endoscopy from Nov. 5-13:
Researchers developed a model that can predict an individual patient's risk to develop advanced precancerous polyps and colon cancer, Medical Xpress reported Nov. 10.
